Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:07 pm Purchase |
2024-12-31 | 13G | NeuroPace, Inc. NPCE |
Kent Lake PR LLC | 1,482,555 4.900% |
10,064 (+0.68%) |
Filing History |
| 2025-02-11 4:38 pm Sale |
2024-12-31 | 13G | NeuroPace, Inc. NPCE |
KCK LTD. | 5,270,845 17.700% |
-283,244 (-5.10%) |
Filing History |
| 2025-02-04 12:50 pm Purchase |
2024-12-31 | 13G | NeuroPace, Inc. NPCE |
MORGAN STANLEY MS |
2,489,391 8.300% |
28,675 (+1.17%) |
Filing History |
| 2024-11-14 6:30 pm Sale |
2024-09-30 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 3,406,335 11.700% |
-597,632 (-14.93%) |
Filing History |
| 2024-11-14 3:36 pm Purchase |
2024-09-30 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 2,433,168 8.200% |
400 (+0.02%) |
Filing History |
| 2024-11-04 4:51 pm Purchase |
2024-10-25 | 13G | NeuroPace, Inc. NPCE |
Kent Lake PR LLC | 1,472,491 5.000% |
1,472,491 (New Position) |
Filing History |
| 2024-10-03 4:46 pm Sale |
2024-09-30 | 13G | NeuroPace, Inc. NPCE |
KCK LTD. | 5,554,089 19.000% |
-39,684 (-0.71%) |
Filing History |
| 2024-02-14 7:00 pm Sale |
2023-12-31 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,003,967 15.200% |
-8,314 (-0.21%) |
Filing History |
| 2024-02-14 4:15 pm Sale |
2023-12-31 | 13G | NeuroPace, Inc. NPCE |
KCK LTD. | 5,593,773 21.300% |
-27,338 (-0.49%) |
Filing History |
| 2024-02-09 1:25 pm Purchase |
2023-12-31 | 13G | NeuroPace, Inc. NPCE |
MORGAN STANLEY MS |
2,460,716 9.400% |
272,123 (+12.43%) |
Filing History |
| 2024-02-09 09:28 am Sale |
2024-02-08 | 13G | NeuroPace, Inc. NPCE |
FMR CORP | 468,081 1.780% |
-981,845 (-67.72%) |
Filing History |
| 2024-02-02 09:20 am Purchase |
2023-12-31 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 2,432,768 9.300% |
63,765 (+2.69%) |
Filing History |
| 2023-02-14 4:48 pm Unchanged |
2022-12-31 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,012,281 16.100% |
0 (Unchanged) |
Filing History |
| 2023-02-14 08:22 am Purchase |
2022-12-31 | 13G | NeuroPace, Inc. NPCE |
Soleus Private Equity Fund I L.P. | 2,369,003 9.500% |
60,000 (+2.60%) |
Filing History |
| 2023-02-10 1:12 pm Purchase |
2022-12-30 | 13G | NeuroPace, Inc. NPCE |
MORGAN STANLEY MS |
2,188,593 8.800% |
2,188,593 (New Position) |
Filing History |
| 2023-02-09 12:01 pm Purchase |
2023-02-09 | 13G | NeuroPace, Inc. NPCE |
FMR CORP | 1,449,926 5.822% |
1,449,926 (New Position) |
Filing History |
| 2022-11-23 5:11 pm Purchase |
2022-11-21 | 13D | NeuroPace, Inc. NPCE |
Accelmed Partners II L.P. | 4,432,948 17.800% |
390,291 (+9.65%) |
Filing History |
| 2022-11-21 07:00 am Purchase |
2022-11-18 | 13D | NeuroPace, Inc. NPCE |
Accelmed Partners II L.P. | 4,042,657 16.200% |
4,042,657 (New Position) |
Filing History |
| 2022-10-07 4:49 pm Purchase |
2021-12-31 | 13G | NeuroPace, Inc. NPCE |
KCK LTD. | 5,621,111 22.990% |
5,621,111 (New Position) |
Filing History |
| 2022-02-11 4:35 pm Unchanged |
2021-12-31 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,012,281 16.500% |
0 (Unchanged) |
Filing History |